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Objective: Despite Level 1b evidence and international consensus that exercise is beneﬁcial in ankylosing
spondylitis (AS), there is a paucity of detailed information to guide exercise prescription, including the
type and dosage of exercise required for the most beneﬁt. This collaborative project, combining evidence
with clinical expertise, was established to develop practical recommendations to guide sustainable
exercise prescription for individuals with AS.
Methods: Using a modiﬁed Delphi technique, 10 clinical questions were generated and a systematic
literature review was conducted for each. Draft recommendations were developed at a 2-day meeting,
based on the integration of evidence summaries and expert opinion. Feedback was obtained from patient
and health professional groups prior to ﬁnalisation.
Results: Recommendations and practice points were developed for the following areas: assessment;
monitoring; safety; disease management; AS-speciﬁc exercise; physical activity; dosage, adherence and
setting. A framework was developed that could also be adapted for exercise in other chronic
musculoskeletal conditions. Feedback suggests that the ﬁnal consensus statement provides useful
information for those seeking to provide best practice exercise prescription for people with AS.
Conclusion: The recommendations provide an up-to-date, evidence-based approach to the full range of
issues related to the use of exercise in AS, as well as identifying evidence gaps for further research. Most
importantly, this includes investigation of aspects of exercise programme design required to produce the
largest effect, long-term adherence with exercise programs and the speciﬁc exercise requirements of
sub-groups of people with AS. Widespread dissemination and implementation of the guidelines will be
required to optimise exercise outcomes.
& 2015 The Authors. Published by Elsevier HS Journals, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).r HS Journals, Inc. This is an open
.millner@dhhs.tas.gov.Introduction
Individuals with ankylosing spondylitis (AS) experience pain
and stiffness, which mainly affects the axial skeleton (spine, hipsaccess article under the CC BY-NC-ND license
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fatigue can also be a prominent symptom [1]. The primary
pathology includes enthesitis, or inﬂammation of the anatomical
region of the bony attachment of tendons, ligaments or joint
capsules [2]. Typically this occurs in the spine; if unchecked,
new bone formation may result in ankylosis, or spinal fusion.
The most common age of onset is in early adulthood, therefore the
lifetime individual impact of AS can be high [3]. Traditionally, the
condition has been managed with a combination of anti-
inﬂammatory medication and exercise, with the latter appearing
anecdotally to be more effective than for other types of arthritis.
Although exercise recommendations feature prominently in
relevant clinical guidelines for the management of ankylosing
spondylitis [4–7], and are supported by a body of mixed-quality
evidence [8], in clinical practice there is a lack of speciﬁc
information to guide exercise planning [9,10]. The majority of
published evidence focuses on mobility exercise [9], and relatively
little attention has been given to other aspects of exercise
programme design such as strengthening, balance or cardio-
respiratory exercise, despite recognition that AS can affect muscle
strength [11], balance [12] and cardio-respiratory function [13].
Similarly, there is little information about dosage (frequency,
intensity and duration) or adherence to recommended programs
[9]. Several trials are based on intensive, time-limited (often
residential) exercise modalities, which are not readily available in
many regions—such as in-patient rehabilitation or spa therapy/
exercise combinations [14]. Lastly, recent rapid advances in med-
ical management, such as tighter control of disease activity by the
use of anti-tumour necrosis factor-alpha (anti-TNFα) agents, have
raised questions about the ongoing relevance of exercise in the
management of AS [15].
The task of developing an optimally effective, evidence based
and sustainable exercise programme for a person or a group with
AS therefore remains challenging. The overall objective of this
project was to develop more speciﬁc recommendations covering a
range of topics which need to be considered for exercise prescrip-
tion—primarily for use by health professionals, but also for people
with AS who may wish to acquire more detailed information about
the use of exercise as a self-management strategy.Methods
Systematic review
The Writing Group (WG) comprised 11 physiotherapist mem-
bers of an ankylosing spondylitis special interest group in Aus-
tralia, and a rheumatologist (J.Z.) with experience in Delphi
methodology and guideline development. WG members inde-
pendently submitted up to 10 questions of clinical importance to
their practice, which were grouped into nine topics by the project
co-ordinators (J.M. and J.Z.). These were assessment, monitoring,
safety, disease management, AS-speciﬁc exercise, physical activity,
dosage, adherence and setting. A systematic review was carried
out for each topic; details of the methods are shown in Appendix A
(Section A1). All WG members then participated in the assessment
of included studies, using a pro forma “article summary” tool to
record quality, relevance to a non-residential setting and reprodu-
cibility of the exercises in a “real-life” context. Meta-analysis was
performed using random effects models where data was available
to allow pooling, that is, for pain, disease activity, spinal mobility
measures (cervical mobility, ﬁngertip to ﬂoor distance, chest
expansion and lumbar ﬂexion) and physical function. An “evidence
matrix” was compiled by the co-ordinators to show the number,
type and quality of studies; overall level of evidence; consistency
of results and (where applicable) effect sizes. Any discrepancieswere resolved by discussion. Details of the ﬂow of studies are
shown in Figure A1, included and excluded full-text papers (with
reasons for exclusion) at A2 and A3 and evidence for the recom-
mendations at Appendix B.
Consensus meeting
A 2-day face-to face meeting was held to review the evidence
and develop recommendations, during which WG members pre-
sented topic summaries, as described above. These ﬁndings were
discussed in the context of the collective clinical experience of the
group, before recommendations were derived for each topic. After
gaining appropriate ethics approval, consumer and health profes-
sional feedback on the draft recommendations was obtained by
anonymously surveying people with AS (via patient support
groups) and health professionals (via professional organisations).
Further information regarding the surveys is provided in Appendix
C, Section 1 (C1). The consensus statement wording was adjusted
and further independent voting by the WG was used to ﬁnalise
each recommendation.
Grade of recommendations
The Australian National Health and Medical Research Council
(NHMRC) hierarchy [16] was used to grade the recommendations
as follows: Evidence-Based Recommendation (EBR) based on a body
of evidence, graded A–D depending on types of studies and
consistency of results; Consensus Based Recommendation (CBR)
developed by the WG in the absence of direct evidence, or poor
quality evidence, to answer the question and Practice Points (PP)
developed by the WG where there was a need to provide practical
guidance to support the implementation of EBRs and CBRs. The
derivation of PPs is shown in Appendix C, Section 2 (C2).Results
The ﬁnal 10 recommendations with practice points are listed at
Box 1. The process of developing the recommendations high-
lighted the complexities of therapeutic exercise prescription and
the potential for multiple interactions between the different topics
examined. Figure 1 summarises the recommendations and rela-
tionships of these factors, and may be useful in informing joint
(patient and health professional) decision making regarding exer-
cise choice. A plain language summary of the recommendations
and framework is also provided in Appendix C, Section 3 (C3).
Survey results (Table C1) demonstrated a high level of patient
importance (mean for all recommendations 8.46/10; range: 8.0–
8.9) and health professional (HP) support (mean ¼ 8.66 and range:
7.3–9.58). The mean proportion of HPs who stated that the
recommendation was already their practice was 60.2%, whilst
21% stated that the recommendation would modify their practice.
0.8% of HPs reported that they did not wish to change their
practice, and the remainder (17.8%) stated that the recommenda-
tion did not apply to their practice. The background, clinical
question(s), results and rationale for each recommendation are
outlined as follows.
Assessment and monitoring
Background
Pre-exercise objective physical measures are an established
component of individual exercise prescription, serving to inform
individual training goals; appropriate exercise type(s); starting
dose precautions (which may indicate exercise modiﬁcation), and
personal information regarding the need for speciﬁc exercise [17].
Box 1–Recommendations and practice points
Exercise for ankylosing spondylitis (AS): a consensus statement
Applicability: People who have AS at any stage, including early disease [96,97]
Recommendation 1: Assessment
Individual exercise prescription should be informed by a thorough and reproducible assessment, which includes musculoskeletal
and psychosocial factors, and AS-specific measures, including objective axial mobility and chest expansion (CBR).
The Bath Ankylosing Spondylitis Metrology Index (BASMI)
[42] is the most widely reported, validated objective axial
mobility measure
BASMI is associated with quality of life, physical function and
psychological status
The BASMI 10-point scoring scale (tabular or linear) is
recommended over the 3-point scale
Imaging review/discussion with medical team may be
indicated for more advanced disease
Tape-based hip internal rotation is a responsive measure for
hip involvement
Strength, balance or cardiorespiratory function should be
assessed as required
Recommendation 2: Monitoring
Sufficient monitoring and feedback should be provided on an individual basis, to achieve confidence and competence with
exercise, and to inform changing needs for exercise prescription. This is recommended at least annually, and more often as
symptoms, function and mobility indicate (CBR).
Feedback, particularly mobility measures, can be important for
exercise adherence.
BASMI raw scores are more sensitive to change than
index scores
In BASMI, lumbar side flexion is the most sensitive
to change
The Edmonton AS Metrology Index (EDASMI) [98] may be
useful for patient self-monitoring
Recommendation 3: Safety
Throughout all aspects of exercise prescription, especially for those with more severe or later disease, the physical changes of AS
must be considered. These include the amount of bony change/ankylosis, balance and mobility changes, osteoporosis and
cardiorespiratory consequences of the disease (CBR).
Most types of exercise are safe for the majority of patients.
However, the following require assessment on a case by case
basis, and may be contra-indicated in more advanced AS:
High velocity or strongly resisted exercise, especially trunk
flexion/rotation
Exercise which excessively challenges balance, postural
stability or cardiorespiratory function (in a non-controlled
environment)
Excessive spinal or peripheral joint mobility gain where
there is adjacent ankylosis
Excessive end range mobility gain following total hip
replacement
High impact exercise/physical activity (e.g., contact sports,
martial arts, four wheel driving, boating in rough seas,
fairground rides)
Recommendation 4: Disease management
Individuals receiving anti-TNFα therapy should continue with regular exercise prescription as it confers an additional benefit to
anti-TNFα therapy alone (EBR, grade B)
Exercise could theoretically be a mediator of inflammation in
AS, but trial results have been conflicting
Stabilisation with anti-TNF therapy can be a “window of
opportunity” to optimise mobility and physical fitness
Recommendation 5: AS-specific exercise—Mobility
Individual exercise prescription with an emphasis on spinal mobility is paramount for best management of AS. Maintaining
mobility of peripheral joints is also essential. This can be achieved through a number of approaches. At this time we are unable
to recommend one approach over another, therefore individual goals should be informed by assessment findings.
(EBR grade A)
Mobility goals may vary from restoration of full spinal range
and normal posture (early, well-controlled disease), to
maintenance of existing range (later disease)
Exercise choice (e.g., specific proprioceptive neuromuscular
facilitation techniques) can be tailored to target movement or
functional deficits
Recommendation 6: AS-specific exercise—other
Stretching, strengthening, cardiopulmonary and functional fitness are important components to include in a balanced exercise
programme (EBR grade A)
There is preliminary evidence for (modified) Pilates and tai chi,
incentive spirometry and global postural re-education as
effective modalities
Recommendation 7: Physical activity
Regular physical activity should be encouraged to promote general health, well-being and functional outcomes (EBR, grade B)
No one activity has been found to be superior
Regular interruption of sedentary activities should also be
encouraged
Occupational, transport and leisure activities contribute to
total physical activity levels
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Recommendation 8: Dosage
Exercise frequency, intensity, duration and type must be tailored to the persons assessment findings, goals and lifestyle.
(a) For mobility, stretch and postural exercise, consistency is the most important factor
(b) For other exercise types, national physical activity guidelines may require modification. Consideration should be given
to disease stage, activity and progression, whilst aiming for optimal effectiveness (EBR, grade C)
Factors which may indicate modification of baseline exercise
dose include pain/fatigue; disease activity and any secondary
AS consequences (cardiorespiratory, ankylosis, osteoporosis,
balance impairment)
Dosage progression (titration) should balance individual
exercise response with training for physiological change
Mobility exercise can be incorporated in regular breaks from
sitting
Short-term more intensive doses may be appropriate for
specific purposes
Recommendation 9: Adherence
It is important to assess adherence with regular exercise, encourage motivation and promote ongoing self-management
(EBR, grade B)
Group settings and monitoring have been shown to support
adherence in AS
Recommendation 10: Exercise setting
Priority should be given to patient preference in exercise choice, to enhance adherence and optimise positive outcomes (CBR).
AS-specific group therapy and warm water exercise may be
beneficial adjuncts to an individual’s regular home exercise
programme
Where available, exercise supervision appears to enhance
effectiveness
Recommendations are shown in bold type, with supporting practice points where there was a need to provide practical guidance to support the recommendation.
Development details, deﬁnitions and evidence are shown in Appendix B (recommendations) and Appendix C (practice points).
Evidence-Based Recommendation (EBR), based on body of evidence[99]:
grade A: Body of evidence can be trusted to guide clinical practice
grade B: Body of evidence can be trusted to guide clinical practice in most situations
grade C: Body of evidence provides some support for recommendation, but care should be taken in its application
grade D: Body of evidence is weak and recommendation should be applied with caution
Consensus Based Recommendation (CBR), developed by the WG where there was insufﬁcient direct (or poor quality) evidence to answer the clinical question.
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which measures are beneﬁcial for baseline mobility assessment in
order to inform exercise prescription? What are the minimum
requirements for monitoring these measures?Results
Although a number of (largely non-controlled) cross-sectional
studies found relationships between axial mobility (anthropo-
metric) measures and self-reported domains such as physical
function, disability and quality of life [18–21], Van Weely [22]
found that self-reported function was typically reported as being
more impaired than objectively measured function. Self-
reported scores therefore do not substitute for objective meas-
ures, and hence the rationale for an accurate assessment that
includes both subjective and objective components. The choice
of AS-speciﬁc tools is further discussed at B1.1 and C2.1, but as a
minimum, validated axial mobility measures and chest expan-
sion should be completed. As reﬂected in the statement below, a
combination of self-reported and objective information usefully
informs exercise prescription and identiﬁes where more detailed
assessment may be indicated. Analysis of such tests is beyond
the scope of this review, but many are simple and quick to
perform in the clinical setting, and may be required to assess the
consequences of more advanced AS on strength, balance or
cardio-respiratory function.
Recommendation 1: Assessment. Individual exercise prescription
should be informed by a thorough and reproducible assessment,
which includes musculoskeletal and psychosocial factors, and
AS-speciﬁc measures, including objective axial mobility and
chest expansion (CBR).
No direct evidence was found to answer the question regarding
monitoring. However, in the experience of the WG, there is alsorationale for longitudinal monitoring of AS anthropomorphical
measures, in order to evaluate exercise effectiveness, assess
change in mobility and provide personal feedback, which may be
motivational. In clinical practice, patients appear to value the
objective information provided by assessment and it appears to
have a positive effect on exercise behaviour [23], hence the
following recommendation.
Recommendation 2: Monitoring. Sufﬁcient monitoring and
feedback should be provided on an individual basis, to achieve
conﬁdence and competence with exercise, and to inform changing
needs for exercise prescription. This is recommended at least
annually, and more often as symptoms, function and mobility
indicate (CBR).
Safety
Background
The WG was anecdotally aware of single case adverse events
associated with exercise, including spinal fracture/cord injury, hip
arthroplasty dislocation and spinal pseudarthrosis/discitis. The
clinical question was: In adults with AS, what safety aspects should
be considered in relation to exercise prescription?
Results
Direct evidence for exercise safety issues (including adverse
events) relating to AS was not found, therefore indirect evidence of
secondary disease consequences was reviewed. The AS population
includes people for whom the risks of exercise are higher than a
non-AS population, secondary to:(a) small increases in cardio-vascular risk factors and ischaemic
heart disease [24];
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Fig. 1. Framework for exercise and ankylosing spondylitis
Aims:
(1) Address primary (musculoskeletal) consequences of AS.
(2) Address secondary consequences of AS (cardio-respiratory, balance, osteoporosis).
(3) Facilitate physical activity according to national guidelines, with modiﬁcation for AS symptoms, severity, activity and duration as required.
The three main types of exercise for a balanced programme are shown in the circle, numbered for the sequence in which they would usually be addressed. The
upper segments of the circle indicate exercise types that are therapeutic, that is, address speciﬁc aspects of AS management. The lower segment addresses exercise for
maintenance of health, similar to the general population. The arrows indicate that there is interaction between the exercise types. The surrounding bars show key aspects of
exercise prescription for consideration throughout the process, from initial assessment to ongoing practice. Finally, the recommendations are broadly applicable and
continue to be relevant, even after commencement of anti-TNFα therapy.
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axial mobility) [13,25];(c) spinal osteoporosis, which appears related to disease activity
and duration, and has an incidence of 18–67% [26];(d) spinal fracture risk in established AS of between 14% and 19%
[27], which (due to the biomechanics of an ankylosed spine) is
more likely to result in spinal cord injury (SCI) than in a non-
ankylosed spine [28] and(e) Impaired balance and righting reactions, again in association
with spinal ankylosis [12].Other less frequent but recognised complications of AS that
may be impacted by inappropriate exercise include discitis/
pseudarthrosis (most prevalent at T11/12 level) [29], anteriortotal hip arthroplasty dislocation [30] and atlanto-axial sublux-
ation [31].
Co-morbidity prevalence was consistently shown to be related
to disease severity and/or duration, so it should be emphasised
that the additional risks described are largely restricted to those
with more advanced disease. However, the potential consequence
for an individual of an adverse event is high, and little attention
has been paid to this aspect of exercise prescription to date.
It seems likely that the beneﬁts of exercise still outweigh the risks
for almost all individuals; however, appropriate exercise prescrip-
tion is paramount for those with more severe disease.
Recommendation 3: Safety. Throughout all aspects of exercise
prescription, especially for those with more severe or advanced
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These include the amount of bony change/ankylosis, balance
and mobility changes, osteoporosis and cardiorespiratory con-
sequences of the disease (CBR).
Disease management
Background
It is not known whether the beneﬁcial effects of exercise in AS
occur at a systemic (e.g., anti-inﬂammatory) or local (e.g., enthesis)
level. In healthy adults, and those with a number of chronic
diseases, exercise can produce systemic anti-inﬂammatory effects,
[32–35], but interactions between exercise and pathology are
complex. It may be that exercise can have either pro or anti-
inﬂammatory consequences for individuals with inﬂammatory
arthritis, depending on the type of exercise and the condition
concerned [36]. Two clinical questions were generated by the WG
on this topic: (1) Is exercise effective in disease modiﬁcation
(reduction in progression), compared with no exercise? and (2) are
exercises in combination with an anti-TNFα medication more
beneﬁcial than medication alone? [15].
Results
Insufﬁcient evidence was found to determine whether exercise
produces local and/or systemic effects in AS, and so a recommen-
dation regarding disease modiﬁcation was not made. However,
two RCTs [37,38], two non-randomised experimental trials [39,40]
and one interrupted time series without controls [41] were
identiﬁed in patients on anti-TNFα therapy. The trials consistently
demonstrated the beneﬁcial effect of a combination of anti-TNFα
therapy and an AS-speciﬁc exercise programme, compared with
either anti-TNFα treatment or exercise alone, for both self-reported
measures (such as function and disease activity) and objective
measures, such as the Bath Ankylosing Spondylitis Metrology
Index (BASMI) [42]. Further detail is shown in Appendix B,
Section 3.
Recommendation 4: Disease management. Individuals receiving
anti-TNFα therapy should continue with regular exercise
prescription as it confers an additional beneﬁt to anti-TNFα
therapy alone (EBR, grade B).
AS-speciﬁc exercise
Background
Traditional goals of exercise in AS have focussed on improving
and/or maintaining physical function and posture by: mobility
exercises for axial and peripheral joints; muscle strengthening
(especially “antigravity” muscles); stretching of speciﬁc muscle
groups; and cardiorespiratory ﬁtness [43]. The combination of soft
tissue stretch and dynamic joint mobility exercises for “tight” or
shortened soft tissues/restricted joints, and improved recruitment
and strengthening of “lengthened”muscles is thought to target the
biomechanical, mobility and postural changes of AS. The clinical
question was: In adults with AS, is therapeutic (speciﬁcally pre-
scribed) exercise aimed at:(a) improving mobility/posture;
(b) increasing strength;
(c) improving cardiorespiratory ﬁtness and
(d) improving function (balance, co-ordination, gait, agility and
proprioception),more beneﬁcial for pain, mobility, disease activity and physical
function than no exercise/general advice only?Results
There were eight systematic reviews (SRs) concerning exercise
interventions that were widely available or could be reproduced in
a non-residential setting. Three [6,8,9] included meta-analysis of
outcome measures, with a consistent trend for small to medium
effects (including pain, physical function, axial mobility and other
self-reported outcome measures), in favour of various exercise
interventions.
A total of 11 individual RCTs met our criteria, and most (9 of 11)
met the commonly used benchmark for a “good quality” study,
with a score of six or more on the Physiotherapy Evidence
Database (PEDro scale) [44]. The results are summarised in
Tables 1 and 2, and in more detail in Appendix B (Section B1.4
and Table B1), and again show a high level of consistency for small
to moderate beneﬁts for pain, disease activity, axial mobility and
function. This was conﬁrmed by our meta-analyses of these
studies, displayed as Forest plots in Figure 2. Statistical hetero-
geneity was low for most outcomes (cervical mobility, ﬁnger to
ﬂoor distance, chest expansion, pain and disease activity) but was
moderate for lumbar ﬂexion and substantial for physical function.
Potential sources of heterogeneity in exercise trials include the
trial participants (in this case, disease severity is particularly
relevant); exercise dosage (including variation in trial duration
and exercise frequency, intensity and time); programme design
(for example, type of exercises, their delivery method and setting)
and trial methodology and quality [45].
While these effects are small to modest, recent academic
discussion has also highlighted the issue of therapeutic validity
of trials [46], that is, whether the exercises described meet guide-
lines for dosages known to produce physiological improvements.
In general, there was poor reporting of exercise goals, programme
design, outcome measures and adherence, and the links between
these components were not speciﬁed. Dosage (particularly inten-
sity) appeared to be insufﬁcient in most trials [9].These factors
may account for the trial effect sizes being somewhat disappoint-
ing, compared with those reported by patients and clinicians.
Overall, the WG found that the consistent evidence of beneﬁts
for exercise in AS was sufﬁcient to form recommendations focus-
sing on axial mobility exercises plus stretch, strength, cardiopul-
monary and functional ﬁtness. Evidence for further speciﬁcity was
not available, and the WG’s clinical question regarding the best
exercise programme could not be fully answered, although bene-
ﬁts for speciﬁc types of exercise could also not be excluded. Given
the large spectrum of disease activity, severity and variation in
presentation of mobility impairment in AS, it seems likely that
“best practice” will continue to be an individualised programme
where exercises are selected to target an improvement (or pre-
vention of deterioration) of identiﬁed postural, biomechanical and
functional changes. Clearly, there is overlap and interaction
between the different exercise categories, but in a balanced
programme, each aspect should facilitate performance of the
other, as shown visually in Figure 1.
Recommendation 5: AS-speciﬁc exercise (mobility). Individual
exercise prescription with an emphasis on spinal mobility is
paramount for best management of AS. Maintaining mobility of
peripheral joints is also essential. This can be achieved through a
number of approaches. At this time we are unable to recommend
one approach over another, therefore individual goals should be
informed by assessment ﬁndings (EBR grade A).
Recommendation 6: AS-speciﬁc exercise (other). Stretching,
strengthening, cardiorespiratory and functional ﬁtness are
important components to include in a balanced exercise
programme (EBR grade B).
Table 1
AS-speciﬁc exercise: interventions and outcomes (pain, disease activity and physical function)
Study Treatment groups
PEDro
Score/10
No. in
group Duration
Assess
point(s)
Outcome SMD (95% CI)
Pain Disease activity Physical function
Altan (2012) [54] Intervention: pilates with trainer,  3/week 8 30 12 weeks Week 12 1.00 (2.00 to 0.00) 0.36 (0.90 to 0.19)
25Control: standard treatment programme Week 24
Analay (2003) [101] Intervention: AS education session; supervised exercise
programme,  3/week
7 23 6 weeks Week 6 0.02 (0.57 to 0.60) 0.39 (0.98 to 0.21)
22 Week 12
Control: AS education session; instruction to perform the
same exercises at home  3/week; weekly progress
phone call
Cagliyan (2007) [77] Intervention: AS education session; supervised exercise
programme  2/week
4 23 12 weeks Week 12 1.00 (1.84 to 0.16) 0.62 (1.21 to 0.03)
23 Week 24
Control: AS education session; instruction to perform
exercises at home; telephone follow-up
Fernandez-de-las-
Penas (2005) [61]
Intervention: weekly supervised exercise session, global
postural re-education method
6 20 16 weeks Week 16 0.02 (0.64 to 0.60) 0.04 (0.66 to 0.58)
20
Control: weekly supervised exercise, using conventional
exercises
Hidding (1993) [102] Intervention: weekly group physiotherapy: mobility/
strengthening exercises, sports and hydrotherapy, plus
daily individual home exercise programme
7 67 36 weeks Week 36 not estimable 0.12 (0.46 to 0.21)
68
Control: daily individual exercise programme
Ince (2006) [103] Intervention: supervised multi-modal exercise programme
(warm-up, aerobic step, stretching and pulmonary
exercises) plus information on exercise beneﬁts
7 15 12 weeks Week 12
15
Control: information on exercise beneﬁts only
Kraag (1990) [58] Intervention: home physiotherapy: combination of
education, passive techniques plus therapeutic exercise
according to individual problem list
8 22 16 weeks Week 16 0.73 (1.31 to 0.14) 1.78 (2.47 to 1.10)
Control: no treatment 26
Lee (2008) [104] Intervention: tai chi for RA programme; plus home practice;
tai chi video; telephoned by researchers  2/week
6 13 8 weeks Week 8 0.03 (1.19 to 1.12)
17
Control: no structured exercise programme; telephoned by
researchers  2/week
Lim (2005) [59] Intervention: home exercise programme (for muscle
relaxation, ﬂexibility, strength, breathing and posture)
taught individually; requested practise was daily  30 min
6 25 8 weeks Week 8 0.34 (0.90 to 0.21) Not estimable 0.67 (1.24 to 0.10)
25
Control: no intervention
Maseiro (2011) [37] Intervention A: educational/behavioural meetings  2,
then exercise training  2/week: ﬂexibility, stretches,
proprioceptive, breathing and endurance. Home practice
 3–4/week requested; exercise DVD and monthly phone
calls.
7 20 6 weeks Week 8 0.63 (1.25 to 0.01) 0.38 (1.72 to 0.96) 0.56 (1.18 to 0.06)
20 Week 24
22
Intervention B: educational/behavioural meetings only
Control: no intervention
So (2012) [60] Intervention: incentive spirometer exercise programme daily,
plus education/conventional home exercise programme
(spinal ﬂexibility, stretches and breathing exercises)
6 23 16 weeks Week 16 0.61 (1.53 to 0.31) 0.36 (0.95 to 0.22)
23
Control: education and individual counselling plus
instruction in a conventional home exercise programme
Overall Effect NB. All in favour of intervention groups 0.42 (0.74 to 0.09) 0.47 (0.84 to 0.09) 0.51 (0.81 to 0.21)
MD ¼ mean difference; SMD ¼ standardised mean difference; PEDro ¼ Physiotherapy evidence database; VAS ¼ visual analogue scale; BASDAI ¼ Bath Ankylosing Spondylitis Disease Activity Index; BASFI ¼ Bath Ankylosing
Spondylitis Functional Index.
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Background
There is a large and compelling body of population-based
evidence regarding the importance of physical activity (PA) for
health [47], resulting in national PA guidelines for “healthy adults”
in most countries. Most current guidelines are based on 150–
300 min of moderate intensity, or 75–150 min of vigorous inten-
sity PA per week, plus muscle strengthening at least twice per
week [48,49]. The WG was interested in the interpretation of such
guidelines for people who have AS, the clinical question being:
which types of physical activity are beneﬁcial for pain, mobility,
disease activity and function?
Results
There is long-standing consensus that sports/activities involv-
ing high impact, such as some football codes, martial arts or
distance road running should be avoided in AS due to the risk of
symptom exacerbation or structural damage to an inﬂamed or
ankylosed spine [43,50]. Similarly, activities that excessively chal-
lenge balance may increase falls risk and should therefore be
avoided. A recent hypothesis [51] suggests that mechanical stress
may have a role in the disease pathology, and if proven this could
further inﬂuence activity choices. For now, the pragmatic advice
remains to avoid high impact activities, particularly in disease that
is more active, severe or long-standing.
Regarding types of widely available leisure activities, three
small RCTs investigated the effects of tai chi [52], swimming [53]
and Pilates [54]. These activities combine aspects of mobility,
strength and functional (neuromotor) training, suggesting that
they could be beneﬁcial in AS, and the trials demonstrated small to
moderate improvements for self-reported and performance-based
measures. A larger survey of 1538 people with AS found an
association with physical activity levels (PALs) and mobility, but
evidence was not found for the superiority of one activity over
another [55].
In summary, there was insufﬁcient evidence to show that one
type of activity is more beneﬁcial, but there is no reason to suggest
that people with AS would not beneﬁt from maintaining PALs as
per the general population. It seems likely that individuals with
early AS would beneﬁt from a different set (and greater range) of
activities than those with later/more advanced disease. In the
latter case, safety factors are paramount and physical activity
guidelines for an older population (such as the National Physical
Activity Recommendations for Older Australians) [56] may be
appropriate.
Recommendation 7: Physical activity. Regular physical activity
should be encouraged to promote general health, well-being and
functional outcomes (EBR, grade B).
Dosage
Background
FITT-VP [17] is a widely used framework for exercise dosage and
comprises six components: frequency (how often); intensity (how
hard); time (duration) and type, resulting in a total exercise
volume with the last component being “progression.” Exercise
dosage should be considered for these parameters in all three of
the exercise components shown in Figure 1; however, the many
variables contributing to an individual’s dose response (including
genetics, pathology, physiology, psychosocial factors and settings/
environments [57]), mean that personalised adaptation of any
recommendations is desirable. A further consideration is the
concept of intensive (larger volume) exercise doses that may be
Fig. 2. Forest plots of meta-analyses; (A) Pain; (B) disease activity (BASDAI); (C) cervical mobility; (D) ﬁnger to ﬂoor distance (cm); (E) chest expansion; SD ¼ standard
deviation; CI ¼ conﬁdence interval.
Meta-analyses of exercise trials for outcome measures of pain, disease activity, mobility (cervical mobility, ﬁnger to ﬂoor distance, chest expansion and lumbar ﬂexion) and
physical function, summarised as Forest plots for included studies. A random effects model was used due to the heterogeneity of the interventions. The boxes represent point
estimates for each study, their size being proportional to the size of study. The horizontal bars represent 95% conﬁdence intervals and the diamond the pooled effect size.
Mean differences were calculated where the same scale was used for all studies, and standardised mean differences (SMD) calculated where different scales were reported.
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sustainable (less intensive, smaller volume) doses for the long
term. For mobility, posture and stretch exercise, there is obviously
an optimal level that can be achieved: once this is attained and is
stable, a “maintenance” dose (rather than progression) is appro-
priate. The clinical question was: In adults with AS, what dosage of
exercise is beneﬁcial for pain, mobility, disease activity and function?
Results
The most extensively analysed exercise dosage is that for PALs
in healthy adults, as per national physical activity guidelines
[48,49]. These are aimed at chronic disease prevention, and the
evidence for long-term therapeutic exercise is less clear.
As can be seen from Table 3, there were limitations to the
reported dosage information in included RCTs. In general, infor-
mation on exercise frequency was available, with “daily” frequency
reported in ﬁve of 11 studies [52,54,58–60], but with a range down
to once per week in one study [61]. Other components of exercise
volume were often not reported, including exercise progression.
The association between volume of habitual exercise in indi-
viduals with AS, and measures of pain, disease activity, mobility
and function were examined in 13 cross-sectional studies, andthese are presented in Table 4. Again, it was difﬁcult to differ-
entiate between exercise types and reported dosage parameters,
and all relied on self-reported measures except Arends et al. [62]
who measured PALs with an accelerometer. Following a survey of
4282 people, Santos et al. [63] suggested that exercise consistency
is the most important factor. This term was not speciﬁed but
appeared to relate to 2–4 h of exercise per week on a sustained
basis. This was supported by Ward [64] in the USA, who found that
back exercises on more than 5 days per week, and recreational
exercises for more than 200 min per week, were associated with a
decrease in pain and stiffness and improvement in function. The
higher frequency of back exercises was also associated with slower
progress of functional disability over 5 years. There was no direct
evidence to suggest a minimally effective stretch time.
Exercise dosage to address the strength, cardiorespiratory and
functional (balance/motor skills) consequences of AS received little
attention in the literature. The study by Dagﬁnrud et al. [9] found
no trials that met ACSM criteria for physiological effectiveness for
strengthening exercises, and only one trial ( of 12) met the criteria
for cardiorespiratory exercise. However, it should also be noted
that there is a curvilinear dose–response relationship with a steep
initial slope [65] and most beneﬁt is therefore to be gained by
Table 3
RCT exercise volume in individuals with AS, compared with pain, disease activity, mobility or function
Author Country
Frequency
(intervention
group) Intensity
Time in minutes/week
(session length if reported) Type
Statistically signiﬁcant beneﬁcial
associations with pain, disease
activity, mobility or function
Altan (2012) [54] Turkey Daily n/a 210 balneotherapy; 210
HEP (30 min sessions)
HEP þ balneotherapy vs HEP only Pain, BASDAI, range of mobility
measures, BASFI—for both groups
Analay (2003) [101] Turkey  3/week “To individual tolerance” 150 (50 min sessions) Stretch, mobility, strength, aerobic Pain; BASFI
Cagliyan (2007) [77] Turkey  2/week n/a 120 (60 min sessions) Joint/spinal mobility, stretching,
strength, respiration, posture
Pain, BASDAI, mobility and BASFI
Fernandez-de-las-Penas
(2005) [61]
Spain  1/week Mobility 2  8–10 reps;
stretches up to 4 min
60 Global Postural Re-education Mobility; function
Hidding (1993) [102] Netherlands  1/week (group)
þ daily HEP
n/a 180 (group); 156 (HEP) Physical training (60); sports(60);
hydrotherapy (60)
Thoraco-lumbar mobility
Ince (2006) [103] Turkey  3/week Low intensity aerobic
(metronome to
standardise intensity)
150 (50 min sessions) Stretch, aerobic, chest expansion Range of mobility measures; physical
work capacity; vital capacity
Kraag (1990) [58] Canada “Daily” n/a n/a Individual exs programme þ manual
techniques
Finger to ﬂoor distance and function
Lee (2008) [104] South Korea Instruction
 2/week; daily
practice
( 2 daily for
last 2 weeks)
n/a 315 (45 min sessions) Tai chi for RA (warm-up, 21 tai chi
movements, cool down)
BASDAI; ﬁnger to ﬂoor distance
Lim (2005) [59] South Korea “Daily” n/a 210 (30 min sessions) HEP—mobility; strength; posture Pain; mobility; function
Masiero (2011) [37] Italy  2/week (group) Mobility 2  10 reps;
Stretches 30–40 s;
aerobic- low speed, no
resistance
120 (60 min group session) Mobility, breathing exs, balance,
posture, proprioception, stretch,
strength, aerobic (walk, treadmill,
cycle)
BASDAI, BASFI, BASMI
 3–4/week
(HEP)
HEP n/a
So (2012) [60] South. Korea Daily Incentive spirometer
breath holds 3–5 s
Incentive spirometer 350;
HEP 350
HEP- mobility; stretch; chest expansion Mobility; BASDAI, BASFI (both
groups); pulmonary function for
incentive spirometer group
HEP ¼ Home Exercise Programme; BASDAI ¼ Bath Ankylosing Spondylitis Disease Activity Index; BASFI ¼ Bath Ankylosing Spondylitis Functional Index; BASMI ¼ Bath Ankylosing Spondylitis Metrology Index.
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Table 4
Habitual (“unsupervised”) exercise volume in individuals with AS, and associations with pain, disease activity, mobility or function
Author Country Subjects Frequency Intensity Time/week Type Other ﬁndings
Arends (2011)
[62]
The Netherlands 55 n/a n/a Measured in kilo
counts/day
(accelerometer)
but values not
stated
PAL for 7 days PAL negatively associated with
inﬂammatory markers, BASFI;
positively associated with
Schobers test, lateral ﬂexion
and neck rotation; no
association with chest
expansion, BASDAI or occiput
to wall distance
Brodin (2007)
[105]
Sweden 50 Never 22%; r  1/week 18%;
 1–2/week but irregular 2%;
Z  2/week 58%
n/a n/a Pool exs; walk; resistance exs;
aerobic exs; cycle; ﬂoorball; golf;
jogging; Nordic walk; tai chi
Higher exercise frequency (4 
2/week) predicted by long
duration of symptoms, prior
exercise habits, higher disease
activity and living alone
Carter (2006)
[69]
UK 131 Daily 35%; 3–5 /week 26%;
 1–2/week 27%; o  1/
week or none 12%
n/a n/a Walk 73%; swim 27%; HEP 18%;
pool exs 14%; cycle 11%
No associations found for pain,
BASDAI
Cooksey (2012)
[106]
UK 326 Moderate-high PAL by IPAQ-SF
score
n/a n/a n/a PALS independently associated
with function
Falkenbach
(2003) [19]
Austria 132 4  2/week 19%;  1–2/
week 36%; o  1/week 45%
n/a n/a Cycle 22%; swim 21%; walk 10%;
other sports 47%
PALS positively associated with
mobility
Falkenbach
(1999) [55]
Austria 132 o  1/week 36%;  1–3/
week 46%; 4  3/week 18%
n/a n/a AS-speciﬁc HEP Exs frequency positively
associated with HAQ score
Fitzpatrick
(2006) [70]
Ireland 198 AS-speciﬁc 5–7 days/week 20% n/a PAL4200 min/
week 30%
n/a Barriers to exercise were lack of
time and motivation, fear of
symptom exacerbation and
fatigue
Haglund (2012)
[107]
Sweden 2167 Criteria met for moderate
( 5–7/week) or vigorous
(2–3/week) physical activity
68%
Criteria for
moderate to
vigorous PAL met
or not met
Exercise sessions
430 min/week
met or not met
n/a 68% met WHO PAL
recommendations for healthy
adults
O'Shea (2008)
[108]
UK 61 Walk  3 /week 35%; stretch
 3/week 32%
n/a n/a n/a High scores for both perceived
beneﬁts and perceived barriers
Santos (1998)
[63]
UK 4282 n/a n/a 0 h 21%; 1 h 20%;
2–4 h 35%; 5–9 h
15%; 410 h 9%
Sport, AS-speciﬁc HEP or
hydrotherapy
2–4 h/week positively associated
with function and inversely
associated with dis. act. 410 h
improved function but not
dis. act.
Sundstrom
(2002) [109]
Sweden 189 Daily 9%;  3–6/week 15%;
 1–2/week 30%; o 1/
week 26%; no exs 17%
n/a n/a Walk 57%; pool exs 38%; cycle 33% Most common exercise barriers
were lack of time and fatigue
Uhrin (2000)
[110]
USA 220 Back exercises: 30% 0 days/
week; 40% 1–4 days/week;
11% 5–7 days/week
n/a Median PAL
85 min/week
Back exs Rec exs—several listed Back exs 45 days/week and rec.
exs 4 200 min/week
associated with decrease in
pain and stiffness,
improvement in function
Ward (2002) [64] USA 212 Back exs 3 7 2.6 days/week n/a Rec. exs. 139 7
161 min/week
Back exs Rec exs—several listed More frequent back exs
associated with slower
progress of functional disability
over 5 years
BASDAI ¼ Bath Ankylosing Spondylitis Disease Activity Index; dis. act. ¼ disease activity; BASFI ¼ Bath Ankylosing Spondylitis Functional Index; exs. ¼ exercises; HAQ ¼ health assessment questionnaire; HEP ¼ home exercise
programme; PAL ¼ physical activity level; Rec. Exs. ¼ Recreational exercises; WHO ¼ World Health Organisation; IPAQ-SF ¼ international physical activity questionnaire short form.
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regular exercise, in other words, “some regular exercise is better
than none.” This may be pertinent to the signiﬁcant proportion of
people with AS who experience persistent pain and/or fatigue [66],
particularly when considering a commencement exercise dosage.
In summary, the relative inﬂuence of many variables is unique
for each person, so a precise “one size ﬁts all” dosage is not
possible, and this is reﬂected in the recommendation. Care should
be taken to balance an individual’s exercise capacity with attaining
an adequate dose for effectiveness. Short-term, more intensive
exercise dosage may be indicated to achieve a speciﬁc goal.
However, long-term “maintenance” AS-speciﬁc dosages should
be realistic and aim for high frequency (5 or more days per week)
and sustainability. This may require compromise from the “ideal”
but the dose–response curve suggests that this may be a better
outcome than short-lived attempts at unsustainable doses.
Recommendation 8: Dosage. Exercise frequency, intensity, duration
and type must be tailored to the person’s assessment ﬁndings,
goals and lifestyle.(a) For mobility, stretch and postural exercise, consistency is the
most important factor and(b) for other exercise types, national physical activity guidelines
may require modiﬁcation. Consideration should be given to
disease stage, activity and progression, whilst aiming for
optimal effectiveness (EBR, grade C).Adherence
Background
The World Health Organisation in its 2003 report “Adherence
to long-term therapies: evidence for action” deﬁned adherence as
“the extent to which a person’s behaviour corresponds with
agreed recommendations from a health care provider”, and further
pointed out that an increase in adherence may be much more
effective than a speciﬁc improvement in treatment for a popula-
tion [67]. For people with AS, the data available (Table 4) suggests
that this is applicable. Predictors for low levels of exercise in cross-
sectional studies appear inconsistent, as they include less disability
[19], increased pain [68,69], increased body mass index (BMI) [70]
and lower spinal mobility [62]. The relevant clinical question was
thereforewhich interventions are beneﬁcial for supporting adherence
to an exercise plan?
Results
Adherence was investigated by Barlow and Barefoot [71] in the
1990s, who noted positive short-term effects on adherence with
self-help groups and education, but long-term effects were not
found. Only one lower quality RCT of participants with AS was
found for which exercise adherence was a primary aim [72], and
long-term information was not provided.
Due to the paucity of research speciﬁc to AS, systematic reviews
investigating strategies to increase adherence to exercise for
chronic musculoskeletal conditions were also considered.
A Cochrane review [73] looking at musculoskeletal pain in adults
found moderate evidence that exercise adherence can be
enhanced, but identiﬁed an urgent need for good quality research
into long-term adherence to exercise interventions. Until that
time, the authors recommended that patient preference should
direct exercise type and setting: however, it should be noted that
AS was a speciﬁc exclusion from this review. Conn et al. [74,75]
investigated physical activity interventions in adults with arthritis ,
and also the effects of education to increase PALs in adults with
chronic illness. Again, there was evidence that PALs can bepositively inﬂuenced by interventions, with an effect size for
educational strategies of 0.45, equivalent to 48 min of physical
activity per week. The former study was a large evidence synthesis
(22,257 subjects with chronic conditions) and suggested the
largest educational effects were those targeting physical activity
behaviour, reinforced by some sort of PAL monitoring. The
latter study found a number of strategies that promote PALs:
these are summarised in Table 5 and reﬂected in the adherence
recommendation.
Recommendation 9: Adherence. It is important to assess adherence
with regular exercise, encourage motivation and promote ongoing
self-management (EBR, grade B).
Exercise setting
Background
A number of settings for exercise in AS have been studied,
including home, clinic/out-patient, gymnasium, out-patient hydro-
therapy pool, other leisure activity/sporting environments, spa
resort/balneotherapy centres (often residential) and in-patient
hospital settings. Balneotherapy refers to baths of warm, mineral-
ised water, usually in combination with both active exercises and
more passive treatments such as massage or mud packs [76]. Many
countries lack access to traditional spa/balneotherapy centres and
so this is not a widely available exercise option, however, “aquatic
physiotherapy” and “warm water exercise” are moderately avail-
able. Residential or hospital in-patient treatment is much less
widely available than in the past. Also relevant here is the mode of
delivery, that is, whether the exercise was performed as part of a
group and with or without health professional “supervision.” The
clinical question was therefore: in adults with AS, which widely
available exercise settings and modes of delivery are beneﬁcial for
pain, disease activity, mobility and function?
Results
The Cochrane review of physiotherapy (exercise based) inter-
ventions for ankylosing spondylitis included 11 trials, with a total
of 763 participants, published prior to January 2007 [8]. The
outcomes analysed were pain, stiffness, spinal mobility, physical
function and patient global assessment, and all interventions were
more beneﬁcial than no intervention or “usual care.” In-patient
spa exercise therapy (an exclusion from our study) plus group
therapy was found to be more effective than group therapy alone;
individual home-based or supervised exercise programs were
better than no intervention, but supervised group physiotherapy
was better than home exercises.
Four further RCTs have been published (Appendix B, Section
1.8), but these collectively demonstrate the difﬁculties in deter-
mining the effects of exercise type versus setting versus mode of
delivery [37,53,54,77]. Although different exercise settings appear
to play a role in overall outcome, it is not possible to quantify
whether beneﬁts are due to the change in setting or environment,
or the consequential support for motivation, adherence and
higher exercise dosage that may arise from supervision and/or a
group mode of delivery. Clinical experience suggests that warm
water exercise may be particularly beneﬁcial for more long-
standing or severe disease. Unfortunately, since it is not possible
to separate the effects of exercise in warm water from other
passive components of spa therapy, there is currently insufﬁcient
evidence to support this clinical impression. Hence, the WG
consensus was that personal preference, local availability and
dosage are more important aspects than setting. However, if
available, group and/or warm water exercise are likely to provide
additional beneﬁt.
Table 5
Intervention attributes or practices that promote physical activity (Adapted with permission from Ruppar and Conn [100].)
Strength of
Evidence Attribute or Practice Deﬁnition
Strong Single target: physical activity only Interventions designed to modify only behaviour related to physical activity, rather than multiple health
behaviours
Behavioural approaches Interventions containing at least one behavioural strategy, designed to produce a direct change in behaviour
related to physical activity
Self-monitoring Interventions including practices such as keeping an activity diary, tracking activity in a calendar, or recording
activity on a website
Moderate Supervised exercise Exercise overseen by a member of the research team or a health care provider
Tailoring Adapting the intervention to meet the needs of the situation or patient
Contracting An agreement between patient and provider deﬁning the level and duration of physical activity the patient will
perform
Exercise prescription Participants receive written instruction for the mode, duration, frequency, intensity and progression of their
physical activity
Fitness testing Patient’s level of physical ﬁtness is evaluated before any physical activity programme is initiated
Stimuli and cues Interventions employ prompts that remind participants to exercise
Moderate or high intensity
recommendations
Recommendations are for moderate or high intensity (as opposed to low intensity) physical activity
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preference in exercise choice to enhance adherence and optimise
positive outcomes (CBR).Discussion
This consensus statement provides the ﬁrst set of comprehen-
sive exercise recommendations to guide practitioners’ exercise
prescription in AS with practical information. As a result of the
consensus process, we developed a framework (Fig. 1) for consid-
ering all clinically relevant aspects of exercise prescription for
people with AS, which has the potential to be adapted to other
chronic musculoskeletal conditions, such as osteoporosis or
osteoarthritis.
The process we followed had a number of strengths and
limitations. The WG brought considerable experience and exper-
tise in the clinical application of exercise in AS, and the develop-
ment of key topic areas facilitated the investigation of all the
important facets of exercise prescription in a way that has not
been previously attempted. However, there were also some limi-
tations to the study. For pragmatic reasons only English language
papers were considered, and papers were initially selected by
one author only; however, included papers were subsequently
independently reviewed by a second author for suitability. Studies
of those with axial spondyloarthritis were not included, and more
focus on this group may be desirable in future. Although one
member of the WG has AS, and additional patient input was
obtained once the draft recommendations were developed, this
process could have been strengthened by inclusion of people with
AS earlier in the process. Professions other than physiotherapy are
also involved in exercise prescription, and broadening of the
representation on the WG could be considered in future reviews.
Although the HP survey results were comparable to external
validity testing for other rheumatology recommendations [78], a
broader range of participants may have strengthened the feedback
process. Lastly, in clinical practice, exercise may be combined with
other non-pharmacological modalities, such as joint mobilisation
[79], and investigation of such treatment combinations was
beyond the scope of this review.
Combining systematic reviews with consensus recommenda-
tions is a lengthy process. In order to address the time lag between
the initial searches and publication, the review for AS-speciﬁc
exercise was repeated for publications until 1st July 2015. A total of
ﬁve SRs (two with meta-analysis) and seven RCTs met theinclusion criteria. The SRs added weight to the recommendations
in terms of support for exercise for improved outcomes [80–84].
More speciﬁcally, there was support for “multi-modal” programs
(the main exercise types as shown in Figure 1) [80,85–87];
cardio-vascular training (as per recommendation 6) [88] and the
synergistic effect of exercise and anti-TNFα medication (recom-
mendation 4) [80,82]. There was preliminary evidence for:
“McKenzie” (a protocol of repeated spinal mobility exercises) in
early AS [89], inspiratory muscle training [90,91] and aquatic
exercise [92] in cohorts with more established disease. However,
there was agreement that “the most effective exercise protocol
remains unclear” [86]. We believe that additional studies targeting
sub-groups such as early or later AS (and the spondyloarthropa-
thies) would enable greater speciﬁcity regarding exercise recom-
mendations in the future; however, the basic framework (Fig. 1)
will apply to all. With regard to exercise settings and supervision,
a SR of home-based exercise found small to moderate beneﬁts
for pain, function, disease activity and depression [81]. However,
reviews by Giannotti et al. [80] and O’Dwyer et al. [84] and a
12-month follow-up to an RCT [93] support supervision and group
components, and a large multi-centre trial in Portugal found only
small measureable gains for a programme with minimal super-
vised exercise practice [94]. These ﬁndings have been reﬂected as
an additional PP (recommendation 10).
As previous authors have noted [9], major concerns regarding
trial quality and clinical relevance remain. In general, future trials
should better describe the exercise interventions and dosage, and
use validated objective measures, such as the BASMI 10-point scale
[95]. Despite consistent ﬁndings that exercise is effective in AS,
the potential interactions between the physiological effects of
exercise and the pathological processes have yet to be clariﬁed.
More knowledge about this could facilitate precise targeting
of exercise effects by more informed programme design. Inves-
tigation of different patient groups (such as those with early, well-
controlled AS versus long-standing, advanced disease) could
determine if stratiﬁcation of patient groups would increase effec-
tiveness: it seems unlikely that “one size”will ever “ﬁt all.” Further
evaluation of the effect of speciﬁc programs to address strength,
cardiorespiratory and functional factors (such as balance), is also
warranted. Exercise programme design should also be clearly
linked to treatment aims and address physiological effectiveness,
including progression: given that some subjects may start from a
relatively low baseline, longer studies are therefore required. Such
programs would allow better titration of dosage and thus may
reﬂect the larger effect sizes that people with AS and clinicians
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provide better objective data on exercise dosage, and studies that
consider long-term outcomes and self-management strategies
would be more relevant to the reality of limited availability of
resources. Lastly, this would better inform the most urgently
needed area of research, which is identiﬁed in this review as
long-term adherence to exercise strategies.Conclusion
The evidence found was of mixed quality, but consistently
supported the beneﬁcial effects of exercise in AS. However, lower
quality research in some areas means that the current approach
remains personalised and targeted to individual therapeutic goals.
The 10 recommendations are speciﬁc enough to be clinically
useful, but ﬂexible for adaptation to the needs of all individuals.
This new framework is summarised in Figure 1, and has the
potential to be adapted for other chronic musculoskeletal con-
ditions. Although developed for the Australian context, the rec-
ommendations would also apply to other regions, particularly
where spa or residential centres are not routinely available, or to
anyone seeking information on long-term exercise strategies.
Widespread dissemination and implementation of the guidelines
will be important to ensure a more consistent approach to AS
exercise management, and optimise outcomes for people with this
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